E-LIB Suche - Ergebnisse für: Kalsekar, Anupama

1

Real-world outcomes with novel therapies in relapsed/refrac..:

Crombie, Jennifer L. ; Jun, Monika ; Wang, Tongsheng...
Leukemia & Lymphoma. , 2024

Link: https://doi.org/10.1080/..

2

Treatment Outcomes with Standard of Care in Relapsed/Refrac..:

Ip, Andrew ; Mutebi, Alex ; Wang, Tongsheng...
Advances in Therapy. 41 (2024) 3 - p. 1226-1244 , 2024

Link: https://doi.org/10.1007/..

3

Improvements in Patient-Reported Outcomes in Relapsed or Re..:

Phillips, Tycel ; Lugtenburg, Pieternella ; Kalsekar, Anupama...
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 3 - p. e78-e87.e2 , 2024

Link: https://doi.org/10.1016/..

4

POSTER: ABCL-612 Real-World Outcomes in Patients With Relap..:

Nastoupil, Loretta J. ; Andersen, Clark ; Ayers, Amy...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S204 , 2023

Link: https://doi.org/10.1016/..

5

ABCL-612 Real-World Outcomes in Patients With Relapsed or R..:

Nastoupil, Loretta J. ; Andersen, Clark ; Ayers, Amy...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S442-S443 , 2023

Link: https://doi.org/10.1016/..

6

P1176: CLINICAL OUTCOMES OF NOVEL THERAPIES IN RELAPSED/REF..:

Crombie, Jennifer ; Jun, Monika ; Wang, Tongsheng...
HemaSphere. 7 (2023) S3 - p. e0888870 , 2023

Link: https://doi.org/10.1097/..

7

P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIEN..:

Ip, Andrew ; Rosenthal, Allison ; Mutebi, Alex...
HemaSphere. 7 (2023) S3 - p. e324937a , 2023

Link: https://doi.org/10.1097/..

8

P1149: COMPARISON OF THE EFFICACY OF EPCORITAMAB VERSUS CHI..:

Rosenthal, Allison ; Jun, Monika ; Munoz, Javier...
HemaSphere. 7 (2023) S3 - p. e9299527 , 2023

Link: https://doi.org/10.1097/..

9

An Epidemiological Model to Estimate the Prevalence of Diff..:

Chihara, Dai ; Johnston, Karissa ; Bolatova, Talshyn...
Clinical Lymphoma Myeloma and Leukemia. 22 (2022) 12 - p. e1092-e1099 , 2022

Link: https://doi.org/10.1016/..

10

Estimating the cost-effectiveness of daclatasvir + sofosbuv..:

McEwan, Phil ; Webster, Samantha ; Ward, Thomas...
Cost Effectiveness and Resource Allocation. 15 (2017) 1 - p. , 2017

Link: https://doi.org/10.1186/..

11

Hepatitis C disease transmission and treatment uptake: impa..:

Bennett, Hayley ; Gordon, Jason ; Jones, Beverley...
The European Journal of Health Economics. 18 (2017) 8 - p. 1001-1011 , 2017

Link: https://www.jstor.org/st..

12

Hepatitis C disease transmission and treatment uptake: impa..:

Bennett, Hayley ; Gordon, Jason ; Jones, Beverley...
The European Journal of Health Economics. 18 (2016) 8 - p. 1001-1011 , 2016

Link: https://doi.org/10.1007/..

13

Daclatasvir and Sofosbuvir Versus Sofosbuvir and Ribavirin ..:

Swallow, Elyse ; Song, Jinlin ; Yuan, Yong...
Clinical Therapeutics. 38 (2016) 2 - p. 404-412 , 2016

Link: https://doi.org/10.1016/..

14

Value of Sustained Virologic Response in Patients with Hepa..:

Ward, Thomas ; Gordon, Jason ; Jones, Beverley...
Clinical Drug Investigation. 37 (2016) 1 - p. 61-70 , 2016

Link: https://doi.org/10.1007/..

15

Estimating the Clinical and Economic Benefit Associated wit..:

McEwan, Phil ; Ward, Thomas ; Bennett, Hayley...
PLOS ONE. 10 (2015) 1 - p. e0117334 , 2015

Link: https://doi.org/10.1371/..